Skip to content

GREEN VISION BIOTECHNOLOGY CORP.

company.status.inactive

CIK 1571804fmd_14R2VAZW49WPJ1EW05R20Z5NAXManufacturing · Agricultural ChemicalsTemplate: Standard

Coverage: Jul 05, 2012 to Jun 30, 2022, 45 periods

Latest annual · FY2021

Millions
Total revenues
0
Gross profit
0
Operating income
1
Net income
(0)

Latest quarter · Q2 FY2022

Millions
Total revenues
0
Gross profit
0
Operating income
(0)
Net income
(0)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2019 to FY2021
+22.0%
Revenue, 5 yearsFY2017 to FY2021
+1.4%
Net income, 5 yearsFY2017 to FY2021
n/m

GREEN VISION BIOTECHNOLOGY CORP. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2021FY2020ChangeSource
Revenue$145,099$86,650+67.5%10-K 2022-03-31 · proof
Gross profit$70,926-$6,56810-K 2022-03-31 · proof
Operating income$521,279$524,751-0.7%10-K 2022-03-31 · proof
Net income-$499,777-$396,02710-K 2022-03-31 · proof
Cash from operating activities-$235,309-$85,60510-K 2022-03-31 · proof
Total assets$2.9 million$3 million-3.8%10-K 2022-03-31 · proof
Total liabilities$10.8 million$10.5 million+3.7%10-K 2022-03-31 · proof
Cash and cash equivalents$6,507$26,734-75.7%10-K 2022-03-31 · proof
What was GREEN VISION BIOTECHNOLOGY CORP.'s revenue in fiscal 2021?
GREEN VISION BIOTECHNOLOGY CORP. reported revenue of $145,099 for fiscal 2021 (the year ended Dec 31, 2021), against $86,650 the year before (+67.5%). Source: the 10-K filed with the SEC on Mar 31, 2022. SEC
What was GREEN VISION BIOTECHNOLOGY CORP.'s gross profit in fiscal 2021?
GREEN VISION BIOTECHNOLOGY CORP. reported gross profit of $70,926 for fiscal 2021 (the year ended Dec 31, 2021), against -$6,568 the year before. Source: the 10-K filed with the SEC on Mar 31, 2022. SEC
What was GREEN VISION BIOTECHNOLOGY CORP.'s operating income in fiscal 2021?
GREEN VISION BIOTECHNOLOGY CORP. reported operating income of $521,279 for fiscal 2021 (the year ended Dec 31, 2021), against $524,751 the year before (-0.7%). Source: the 10-K filed with the SEC on Mar 31, 2022. SEC
What was GREEN VISION BIOTECHNOLOGY CORP.'s net income in fiscal 2021?
GREEN VISION BIOTECHNOLOGY CORP. reported net income of -$499,777 for fiscal 2021 (the year ended Dec 31, 2021), against -$396,027 the year before. Source: the 10-K filed with the SEC on Mar 31, 2022. SEC
What was GREEN VISION BIOTECHNOLOGY CORP.'s cash from operating activities in fiscal 2021?
GREEN VISION BIOTECHNOLOGY CORP. reported cash from operating activities of -$235,309 for fiscal 2021 (the year ended Dec 31, 2021), against -$85,605 the year before. Source: the 10-K filed with the SEC on Mar 31, 2022. SEC
What are GREEN VISION BIOTECHNOLOGY CORP.'s total assets?
As of Dec 31, 2021, GREEN VISION BIOTECHNOLOGY CORP. reported total assets of $2.9 million, against $3 million a year earlier (-3.8%). Source: the 10-K filed with the SEC on Mar 31, 2022. SEC
What are GREEN VISION BIOTECHNOLOGY CORP.'s total liabilities?
As of Dec 31, 2021, GREEN VISION BIOTECHNOLOGY CORP. reported total liabilities of $10.8 million, against $10.5 million a year earlier (+3.7%). Source: the 10-K filed with the SEC on Mar 31, 2022. SEC
What are GREEN VISION BIOTECHNOLOGY CORP.'s cash and cash equivalents?
As of Dec 31, 2021, GREEN VISION BIOTECHNOLOGY CORP. reported cash and cash equivalents of $6,507, against $26,734 a year earlier (-75.7%). Source: the 10-K filed with the SEC on Mar 31, 2022. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1571804&period_type=annual&limit=5"

Information only, not investment advice.